Summary
Treatment by heterologous DNA administered after whole-body irradiation improved survival and accelerated the recovery of body-weight and of the counts of red blood cells, granulocytes and lymphocytes in the peripheral blood. There was no secondary disease or change in the blood count during the next 12 months.